The Role of Micronutrients in Neurological Disorders

被引:11
|
作者
Brodska, Helena Lahoda [1 ,2 ]
Klempir, Jiri [3 ,4 ,5 ]
Zavora, Jan [1 ,2 ,6 ,8 ]
Kohout, Pavel [7 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, U Nemocnice 499-2, Prague 12808, Czech Republic
[2] Gen Univ Hosp Prague, U Nemocnice 499-2, Prague 12808, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Neurol, Katerinska 30, Prague 12000, Czech Republic
[4] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Katerinska 30, Prague 12000, Czech Republic
[5] Gen Univ Hosp Prague, Katerinska 30, Prague 12000, Czech Republic
[6] Palacky Univ, Fac Med & Dent, Dept Microbiol, Hnevotinska 3, Olomouc, Czech Republic
[7] Charles Univ Prague, Fac Med 3, Clin Internal Med, Videnska 800, Prague 14059, Czech Republic
[8] Thomayer Univ Hosp, Videnska 800, Prague 14059, Czech Republic
关键词
micronutrients; neurodegenerative disorders; autoimmune disorders; stroke; Parkinson's disease; Huntington's disease; neuropathy; multiple sclerosis; epilepsy; VITAMIN-C; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; DIETARY-INTAKE; RISK; SUPPLEMENTATION; MECHANISMS; STROKE; INJURY; NEUROPATHOLOGY;
D O I
10.3390/nu15194129
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Trace elements and vitamins, collectively known as micronutrients, are essential for basic metabolic reactions in the human body. Their deficiency or, on the contrary, an increased amount can lead to serious disorders. Research in recent years has shown that long-term abnormal levels of micronutrients may be involved in the etiopathogenesis of some neurological diseases. Acute and chronic alterations in micronutrient levels may cause other serious complications in neurological diseases. Our aim was to summarize the knowledge about micronutrients in relation to selected neurological diseases and comment on their importance and the possibilities of therapeutic intervention in clinical practice.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Role of functional imaging in neurological disorders
    Weiller, Cornelius
    May, Arne
    Sach, Miriam
    Buhmann, Carsten
    Rijntjes, Michel
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2006, 23 (06) : 840 - 850
  • [22] The role of glycosphingolipids in the pathophysiology of neurological disorders
    Duvar, S
    Suzuki, M
    Yu, RK
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 : S67 - S67
  • [23] The role of electromagnetic fields in neurological disorders
    Mortazavi, S. A. R.
    Mortazavi, S. M. J.
    Paknahad, Maryam
    JOURNAL OF CHEMICAL NEUROANATOMY, 2016, 77 : 78 - 79
  • [24] The role of antiglycolipid antibodies in neurological disorders
    Fredman, P
    SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 341 - 352
  • [25] Elongator - an emerging role in neurological disorders
    Nguyen, Laurent
    Humbert, Sandrine
    Saudou, Frederic
    Chariot, Alain
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (01) : 1 - 6
  • [26] ROLE OF NEUROLOGICAL DISORDERS AND EPILEPSY IN PARTICULAR
    GASTAUT, MH
    SEMAINE DES HOPITAUX, 1983, 59 (02): : 137 - 138
  • [27] The neuroprotective role of melatonin in neurological disorders
    Alghamdi, B. S.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (07) : 1136 - 1149
  • [28] Role of Endogenous Lipopolysaccharides in Neurological Disorders
    Kalyan, Manjunath
    Tousif, Ahmed Hediyal
    Sonali, Sharma
    Vichitra, Chandrasekaran
    Sunanda, Tuladhar
    Praveenraj, Sankar Simla
    Ray, Bipul
    Gorantla, Vasavi Rakesh
    Rungratanawanich, Wiramon
    Mahalakshmi, Arehally M.
    Qoronfleh, M. Walid
    Monaghan, Tanya M.
    Song, Byoung-Joon
    Essa, Musthafa Mohamed
    Chidambaram, Saravana Babu
    CELLS, 2022, 11 (24)
  • [29] Role of RAGE in the Pathogenesis of Neurological Disorders
    Juranek, Judyta
    Mukherjee, Konark
    Kordas, Bernard
    Zalecki, Michal
    Korytko, Agnieszka
    Zglejc-Waszak, Kamila
    Szuszkiewicz, Jaroslaw
    Banach, Marta
    NEUROSCIENCE BULLETIN, 2022, 38 (10) : 1248 - 1262
  • [30] THE THERAPEUTIC ROLE OF GANGLIOSIDES IN NEUROLOGICAL DISORDERS
    SCHNEIDER, JS
    CNS DRUGS, 1994, 1 (03) : 213 - 222